Santa Barbara, California – April 27th, 2023 Santa Barbara Nutrients (SBN) is delighted to announce the appointment of Jessianna Saville to SBN’s advisory board, where she will bring her 17 years of renal nutrition experience as well as knowledge of building and...
Dr. Chris Leamon joins SBN’s Advisory Board
Santa Barbara Nutrients announces new advisory board member, Dr. Chris Leamon, leader in pharmaceutical research
Santa Barbara, California – March 23rd, 2022
Santa Barbara Nutrients (SBN) is pleased to announce that Dr. Chris Leamon has joined its advisory board. Dr. Leamon earned an ACS-certified B.S. degree in Chemistry from Baldwin Wallace University and a Ph.D. in Chemistry from Purdue University. He began his professional career in the pharmaceutical industry where he conducted targeted drug delivery research in the fields of peptide, oligonucleotide, liposome and DNA drug delivery for GlaxoSmithKline, Inc. and Ionis Pharmaceuticals.
He later helped to establish Endocyte, Inc. where he was a named executive officer. While there he led the Company’s targeted drug discovery division, which included oncology, inflammation and polycystic kidney disease programs, for 20 years until its 2018 acquisition by Novartis. Following a 3-year integration, Dr. Leamon left Novartis to become Chief Scientific Officer at Fusion Pharmaceuticals to help advance a diverse pipeline of targeted radiopharmaceuticals for cancer therapy.
Dr. Leamon has published over 90 articles and is an inventor on more than 60 issued or submitted patents. Importantly, in 2015 he was the recipient of the 2015 American Chemical Society, George and Christine Sosnovsky Award for Cancer Research. To date, Dr. Leamon’s efforts have yielded 8 clinically investigated imaging and therapeutic agents for the treatment of cancer.
About Santa Barbara Nutrients, Inc.
Santa Barbara Nutrients is a public benefit corporation incorporated in Delaware and headquartered in Santa Barbara,California. The experienced SBN team is composed of kidney researchers, patients, and other industry professionals dedicated to bringing to market novel medical foods and other innovative products to help people with polycystic kidney disease (PKD) and other renal diseases.
The company is committed to scientific and clinical research to develop science backed products that support human health and address significant unmet medical needs.
For more information, please visit www.SantaBarbaraNutrients.com
Email: Info@SantaBarbaraNutrients.com | Phone: 1+805-272-0029
International Business Leader, Gregg Betz, Joins Santa Barbara Nutrients as Chief Executive Officer
Santa Barbara, California – May 22th, 2023 Santa Barbara Nutrients (SBN) is delighted to announce the appointment of Mr. Gregg Betz as Chief Executive Officer. With over 30 years of leadership across multiple industries and numerous countries, Gregg’s experience will...
Pain Improvement in Polycystic Kidney Disease Among Participants of the Ren-Nu Program
May 9, 2022 - Thomas Weimbs, PhD & Jessianna Saville, RDN Autosomal dominant polycystic kidney disease (PKD) is a common genetic disorder with limited drug therapy options. PKD progresses relentlessly leading to dramatic and often painful kidney and liver...
Glenn Frommer joins SBN Board, PKD Advocate and Investor
Santa Barbara, CA, USA | April 27, 2023 Santa Barbara Nutrients (SBN) is delighted to announce the appointment of Mr. Glenn Frommer to SBN’s Board of Directors which expands the Board to five members. Glenn will leverage the experience from his nearly 40 years of...